Tim A Ahles1, Elizabeth Schofield2, Yuelin Li2, Elizabeth Ryan2, James C Root2, Sunita K Patel3, Katrazyna McNeal2, Alexandra Gaynor2, Heidi Tan3, Vani Katheria3, Jessica Vazquez3, Tiffany Traina4, Arti Hurria5. 1. Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: ahlest@mskcc.org. 2. Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 3. Departments of Population Science and Supportive Care Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. 4. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 5. Center for Cancer and Ageing, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Abstract
INTRODUCTION: The relationship between cognitive function and frailty in older, long-term breast cancer survivors was examined. MATERIALS AND METHODS: Breast cancer survivors who were diagnosed and treated at 60 years of age or above and were 5-15 year disease-free survivors and non-cancer controls matched on age and education were evaluated with neuropsychological tests and the Comprehensive Geriatric Assessment which was used to assess frailty based on a deficit accumulation frailty index (DAFI). RESULTS: Unadjusted regression analyses revealed that cancer survivors scored significantly lower on the Language (P = 0.015), Attention, Processing Speed, Executive Function (APE) (P = 0.015), and Learning and Memory (LM) (P = 0.023) domains compared to controls. However, only the LM domain remained significantly different (P = 0.002) in the adjusted analysis. Survivors had significantly higher DAFI scores compared to controls (p = 0.006) and significantly more survivors were categorized as pre-frail or frail (35%) compared to controls (23%, P = 0.009). Increasing frailty scores were associated with worse cognitive performance across all domains (all Ps ≤ 0.004). For the LM domain, there was a significant interaction (P = 0.019) between DAFI score and survivorship vs control status. Survivors demonstrated a significant linear decline in LM scores as DAFI scores increased, whereas controls demonstrated comparable scores between the robust and pre-frail DAFI groups, demonstrating decline in the frailty group only. CONCLUSION: Older, long-term breast cancer survivors had lower cognitive performance and higher levels of frailty compared to controls. For the Learning and Memory domain, the decline in performance began in the pre-frail range for survivors, but not controls.
INTRODUCTION: The relationship between cognitive function and frailty in older, long-term breast cancer survivors was examined. MATERIALS AND METHODS: Breast cancer survivors who were diagnosed and treated at 60 years of age or above and were 5-15 year disease-free survivors and non-cancer controls matched on age and education were evaluated with neuropsychological tests and the Comprehensive Geriatric Assessment which was used to assess frailty based on a deficit accumulation frailty index (DAFI). RESULTS: Unadjusted regression analyses revealed that cancer survivors scored significantly lower on the Language (P = 0.015), Attention, Processing Speed, Executive Function (APE) (P = 0.015), and Learning and Memory (LM) (P = 0.023) domains compared to controls. However, only the LM domain remained significantly different (P = 0.002) in the adjusted analysis. Survivors had significantly higher DAFI scores compared to controls (p = 0.006) and significantly more survivors were categorized as pre-frail or frail (35%) compared to controls (23%, P = 0.009). Increasing frailty scores were associated with worse cognitive performance across all domains (all Ps ≤ 0.004). For the LM domain, there was a significant interaction (P = 0.019) between DAFI score and survivorship vs control status. Survivors demonstrated a significant linear decline in LM scores as DAFI scores increased, whereas controls demonstrated comparable scores between the robust and pre-frail DAFI groups, demonstrating decline in the frailty group only. CONCLUSION: Older, long-term breast cancer survivors had lower cognitive performance and higher levels of frailty compared to controls. For the Learning and Memory domain, the decline in performance began in the pre-frail range for survivors, but not controls.
Authors: Arti Hurria; Enrique Soto-Perez-de-Celis; Jacob B Allred; Harvey Jay Cohen; Anait Arsenyan; Karla Ballman; Jennifer Le-Rademacher; Aminah Jatoi; Julie Filo; Jeanne Mandelblatt; Jacqueline M Lafky; Gretchen Kimmick; Heidi D Klepin; Rachel A Freedman; Harold Burstein; Julie Gralow; Antonio C Wolff; Gustav Magrinat; Myra Barginear; Hyman Muss Journal: J Am Geriatr Soc Date: 2018-08-26 Impact factor: 5.562
Authors: Jeanne S Mandelblatt; Xingtao Zhou; Brent J Small; Jaeil Ahn; Wanting Zhai; Tim Ahles; Martine Extermann; Deena Graham; Paul B Jacobsen; Heather Jim; Brenna C McDonald; Sunita J Patel; James C Root; Andrew J Saykin; Harvey Jay Cohen; Judith E Carroll Journal: J Natl Cancer Inst Date: 2021-08-02 Impact factor: 13.506
Authors: Jeanne S Mandelblatt; Brent J Small; Gheorghe Luta; Arti Hurria; Heather Jim; Brenna C McDonald; Deena Graham; Xingtao Zhou; Jonathan Clapp; Wanting Zhai; Elizabeth Breen; Judith E Carroll; Neelima Denduluri; Asma Dilawari; Martine Extermann; Claudine Isaacs; Paul B Jacobsen; Lindsay C Kobayashi; Kelly Holohan Nudelman; James Root; Robert A Stern; Danielle Tometich; Raymond Turner; John W VanMeter; Andrew J Saykin; Tim Ahles Journal: J Clin Oncol Date: 2018-10-03 Impact factor: 44.544
Authors: Anna Barata; Aasha I Hoogland; Anuhya Kommalapati; Jennifer Logue; Taylor Welniak; Kelly A Hyland; Sarah L Eisel; Brent J Small; Reena V Jayani; Margaret Booth-Jones; Laura B Oswald; Brian D Gonzalez; Kedar S Kirtane; Michael D Jain; Sepideh Mokhtari; Julio C Chavez; Aleksandr Lazaryan; Bijal D Shah; Frederick L Locke; Heather S L Jim Journal: Transplant Cell Ther Date: 2022-05-14
Authors: Tim A Ahles; Irene Orlow; Elizabeth Schofield; Yuelin Li; Elizabeth Ryan; James C Root; Sunita K Patel; Katrazyna McNeal; Alexandra Gaynor; Heidi Tan; Vani Katheria; Jessica Vazquez; Sergio Corrales-Guerrero; Keimya Sadeghi; Tiffany Traina; Arti Hurria Journal: J Cancer Surviv Date: 2022-10-24 Impact factor: 4.062
Authors: Janette L Vardy; Gregory R Pond; Lucette A Cysique; Thomas M Gates; Jim Lagopoulos; Corrinne Renton; Louise M Waite; Ian F Tannock; Haryana M Dhillon Journal: Support Care Cancer Date: 2022-04-14 Impact factor: 3.359